Eliminated patient fee and changes in dispensing patterns of asthma medication in children—An interrupted time series analysis
Authors:
- 12 June 2019
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 125 (4) , 360-369
Abstract
In 2016, all prescription drugs included in the reimbursement system in Sweden were made available for children (age 0‐17 years) without any patient fees. Our aim was to estimate the association between this intervention and the dispensing patterns of asthma medications among children. Dispensing data on asthma medications for all children living in Stockholm County during 2014‐2017 were selected to include two years before (January 2014‐December 2015) and after (January 2016‐December 2017) the intervention. In an uncontrolled before and after study, the measures of utilization were as follows: the proportion of children with at least one dispensed asthma medication (prevalence); the number of children initiated on treatment after an 18‐month drug‐free period (incidence); the number of defined daily doses (DDDs) dispensed per child; and the number of children with at least two prescriptions with controller medication (inhaled corticosteroid or leukotriene receptor antagonist) dispensed during 18 months (persistence). In an interrupted time series (ITS) analysis, all measures were included except for persistence. Socio‐economic status was defined using Mosaic data. The prevalence increased after the intervention (from 11.9% to 13.0%). However, the ITS analysis showed a positive trend already before the intervention, and consequently, the increase was not attributable to the intervention. For incidence, similar patterns were observed. There was an increase in dispensed volumes related to the intervention, 46.3 DDDs/child/month before and 51.1 after the intervention (P‐value 0.01). The proportion of children with persistent asthma medication increased from 46.0% to 51.9% in children with low socio‐economic status. In conclusion, the intervention was only modestly associated with changes in the dispensing patterns of asthma medication, with the volume dispensed per child increasing slightly, particularly in children with low socio‐economic status.Keywords
Funding Information
- Stockholms Läns Landsting
This publication has 20 references indexed in Scilit:
- High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public healthBMC Public Health, 2013
- Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care recordsBMC Public Health, 2013
- The Effect of Copayments for Prescriptions on Adherence to Prescription Medicines in Publicly Insured Populations; A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthmaAnnals of Allergy, Asthma & Immunology, 2011
- Insights into social disparities in smoking prevalence using Mosaic, a novel measure of socioeconomic status: an analysis using a large primary care datasetBMC Public Health, 2010
- Soft regulations in pharmaceutical policy makingApplied Health Economics and Health Policy, 2009
- Drug prescriptions to outpatient children: a review of the literatureEuropean Journal of Clinical Pharmacology, 2009
- Treatment with inhaled corticosteroids in asthma is too often discontinuedPharmacoepidemiology and Drug Safety, 2008
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002
- Inhaled Corticosteroids for Asthma TherapyChest, 2000